Deep learning for polygenic score analysis for Alzheimer’s disease risk prediction in the Chinese population

Background Alzheimer’s disease (AD) is a leading cause of mortality in the elderly. Genetics studies have identified variants associated with AD. Moreover, Polygenic score analysis can infer the risk of developing AD solely on the basis of genotype information. Method Whole‐genome sequencing was per...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alzheimer's & dementia 2021-12, Vol.17, p.e056625-n/a
Hauptverfasser: Zhou, Xiaopu, Chen, Yu, Ip, Fanny C. F., JIANG, Yuanbing, Cao, Han, Zhong, Huan, Chen, Yuewen, Chen, Jiahang, Zhang, Yulin, Ma, Shuangshuang, Lai, Nicole Chit Hang, Lo, Ronnie M.N., Cheung, Kit, Tong, Estella Pui‐Sze, Mok, Kin Y, Hardy, John, Guo, Qihao, Mok, Vincent C.T., Kwok, Timothy CY, Chen, Lei, Fu, Amy K.Y., Ip, Nancy Y.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Alzheimer’s disease (AD) is a leading cause of mortality in the elderly. Genetics studies have identified variants associated with AD. Moreover, Polygenic score analysis can infer the risk of developing AD solely on the basis of genotype information. Method Whole‐genome sequencing was performed in 2 AD cohorts recruited from mainland China (n = 2,340) and Hong Kong (n = 1,009). Genotype and phenotype data were input into a neural network model that output a polygenic score. Regression analysis was subsequently conducted to examine the associations between the resultant polygenic scores and AD plasma biomarkers. Result The resultant polygenic scores were associated with AD pathogenesis and the levels of specific AD plasma biomarkers in the Chinese population. Conclusion The results suggest that deep‐learning methods have utility for investigating the underlying mechanisms of AD and promote the possibility of developing a genotype‐based strategy for AD risk prediction.
ISSN:1552-5260
1552-5279
DOI:10.1002/alz.056625